NEC Corporation (NEC; TSE: 6701) will begin offering its "NEC AI Agent Service for Procurement Negotiations" in Japan starting this December. This service utilizes NEC's proprietary AI technology, "Automated Negotiation AI," to autonomously generate optimal transaction terms for procurement operations in the manufacturing industry and to negotiate with suppliers. This service automates complex delivery date […]
DAYTON, OH / ACCESS Newswire / December 3, 2025 / Frownies, the 136-year-old family-owned skincare company known for its iconic Facial Patches, proudly announces the launch of its Full Face Collagen Mask, a two-piece hydrogel mask crafted to boost hydration and help the skin appear smoother and more plump-looking overnight. This new release expands Frownies’
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused clinical-stage biopharmaceutical company, today issued a comprehensive update on its therapeutic pipeline. The Company detailed meaningful progress across HT-001, HT-KIT, HT-ALZ, and its newly launched GDNF-based metabolic program, while continuing to strengthen its global intellectual-property portfolio and expand strategic research partnerships. https://mma.prnewswire.com/media/644804/Hoth_Therapeutics_Logo.jpg Pipeline Highlights HT-001 (Topical Epidermal Growth
(NASDAQ:SNPS), LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 30, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS) securities between December 4,
Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit GlobeNewswire December 03, 2025 LOS ANGELES, Dec. 03, 2025 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP reminds investors of the upcoming December 30, 2025 deadline to file a lead plaintiff motion in the
RapDev is thrilled to announce that it ranked 4th on The Boston Globe's 2025 Top Places to Work. For the first time, RapDev was evaluated in the medium-sized company category, reflecting the company's significant growth and continued momentum. The annual list highlights 175 Massachusetts companies whose employees rate them highest for culture, satisfaction, and overall
Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today that it has entered into definitive agreements for the purchase and sale of 12,500,000 ordinary shares (or ordinary share equivalents) and preferred investment options to purchase up to an aggregate
Toronto, Ontario–(Newsfile Corp. – Le 3 décembre/December 2025) – Trulieve Cannabis Corp. (“Trulieve”), has announced it has issued a notice of redemption for all of its outstanding 8.0% senior secured notes due in 2026 (the “Notes”). The aggregate principal amount of the Notes currently outstanding is US$368,000,000. As set forth in the notice of redemption,
Sales of patented medicines in Canada were $22.1 billion in 2024, a 10.9% increaseover the year before The Honourable Marjorie Michel, Federal Minister of Health, today tabled the 2024 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the Senate and the House of Commons. The 2024 Annual Report reviews
Civaris Capital Management, LP (“Civaris”), a private investment firm specializing in optimizing human capital assets, today announced an exclusive partnership with Barry Conchie and Sarah Dalton of Conchie Associates LLC (“Conchie Associates”), a globally recognized leadership advisory firm known for the accuracy of its quantitative assessment tools that use data to predict human capital's impact